These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3677010)

  • 1. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?
    Jordan AM; Weingarten J; Murphy WM
    Cancer; 1987 Dec; 60(11):2766-74. PubMed ID: 3677010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H; Leong AS
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.
    Angulo JC; Lopez JI; Flores N; Toledo JD
    J Cancer Res Clin Oncol; 1993; 119(10):578-93. PubMed ID: 8335677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors in 243 transitional carcinomas of the bladder (II): microscopic parameters of the tumor and staging].
    Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Gómez MA; Concepción Masip T; Fernández Gómez JM
    Arch Esp Urol; 1991 Mar; 44(2):161-8. PubMed ID: 1867491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis.
    Collan Y; Mäkinen J; Heikkinen A
    Eur Urol; 1979; 5(5):311-8. PubMed ID: 446506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading.
    Gilbert HA; Logan JL; Kagan AR; Friedman HA; Cove JK; Fox M; Muldoon TM; Lonni YW; Rowe JH; Cooper JF; Nussbaum H; Chan P; Rao A; Starr A
    J Urol; 1978 Apr; 119(4):488-92. PubMed ID: 650752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphometric study of transitional carcinoma of the bladder (II): analysis of 95 infiltrating tumors].
    Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Gómez MA; Concepción Masip T; Fernández Gómez JM
    Arch Esp Urol; 1991 Apr; 44(3):251-6. PubMed ID: 1867505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder.
    Kakizoe T; Tobisu K; Takai K; Tanaka Y; Kishi K; Teshima S
    Cancer Res; 1988 Apr; 48(8):2299-303. PubMed ID: 3349494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
    Zaleski M; Gogoj A; Walter V; Raman JD; Kaag M; Merrill SB; Drabick J; Joshi M; Holder S; DeGraff DJ; Warrick JI
    Hum Pathol; 2019 Feb; 84():275-282. PubMed ID: 30359638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder.
    Golabesk T; Palou J; Rodriguez O; Parada R; Skrobot S; Peña JA; Villavicencio H
    Urology; 2017 Feb; 100():145-150. PubMed ID: 27765584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance and comparison with other prognostic parameters.
    Schapers RF; Pauwels RP; Wijnen JT; Arends JW; Thunnissen FB; Coebergh JW; Smeets AW; Bosman FT
    Br J Urol; 1994 Jun; 73(6):625-31. PubMed ID: 8032828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.
    van Rhijn BW; Vis AN; van der Kwast TH; Kirkels WJ; Radvanyi F; Ooms EC; Chopin DK; Boevé ER; Jöbsis AC; Zwarthoff EC
    J Clin Oncol; 2003 May; 21(10):1912-21. PubMed ID: 12743143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy.
    Torti FM; Lum BL
    Cancer; 1987 Feb; 59(3 Suppl):613-6. PubMed ID: 2433019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.